Search
Search Results
Found 13 items.
-
Study of risk factors and clinical management of patients with clinical non-response due to low plasma levels of anti-tubercular drugs
Published: July 23, 2024446PDF_EARLY VIEW: 154 -
Prescription patterns and drug utilization in respiratory tract infections: implications for antimicrobial stewardship at a tertiary care teaching hospital
Published: December 23, 2024439PDF_EARLY VIEW: 128SUPPLEMENTARY MATERIAL: 11 -
Demographics and microbiological profile of Pneumonia in United Arab Emirates
Published: February 15, 20161397PDF: 682 -
Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study
Published: January 14, 20211246PDF: 620 -
Prolonged hospitalisation for immigrants and high risk patients with positive smear pulmonary tuberculosis
Published: December 10, 2015846PDF: 521 -
Respiratory pathogens in patients with acute exacerbation of non-cystic fibrosis bronchiectasis from a developing country
Published: April 22, 20211418PDF: 831 -
Factors associated with unfavourable treatment outcomes in people with HIV-associated tuberculosis in Armenia, 2015 to 2019
Published: January 14, 20211139PDF: 578 -
Determinants, risk factors and spatial analysis of multi-drug resistant pulmonary tuberculosis in Jodhpur, India
Published: January 18, 20222423PDF: 1446 -
Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19
Published: January 14, 20212529PDF: 1211Supplementary: 175 -
Comparison of efficacy of bedaquiline and moxifloxacin in drug resistant pulmonary tuberculosis. A prospective observational study
Published: May 4, 20221591PDF: 314 -
Role of GeneXpert in the diagnosis of extrapulmonary tuberculosis
Published: July 25, 2024376PDF_EARLY VIEW: 190 -
Multidrug-resistant tuberculosis in Iran: a multicenter study
Published: January 12, 2024738PDF_EARLY VIEW: 304 -
Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018
Published: January 14, 20211639PDF: 829Supplementary: 128
1 - 13 of 13 items